Arvinas (ARVN) FCF Margin (QoQ) (2018 - 2026)
Powered by 
Analysis
Arvinas (ARVN) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Arvinas | 607.18 Mn | 39.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43,250.00 |
| Mar 31, 2026 | -12,982.00 |
| Dec 31, 2025 | -18,082.00 |
| Sep 30, 2025 | 28,996.00 |
| Jun 30, 2025 | -38,395.00 |
| Mar 31, 2025 | 9,527.00 |
| Dec 31, 2024 | -1,688.00 |
| Sep 30, 2024 | -19,052.00 |
| Jun 30, 2024 | 45,061.00 |
| Mar 31, 2024 | -57,881.00 |
| Dec 31, 2023 | 44,131.00 |
| Sep 30, 2023 | -8,441.00 |
| Jun 30, 2023 | 12,015.00 |
| Mar 31, 2023 | -9,273.00 |
| Dec 31, 2022 | 1,596.00 |
| Sep 30, 2022 | 2,946.00 |
| Jun 30, 2022 | -1,329.00 |
| Mar 31, 2022 | -11,014.00 |
| Dec 31, 2021 | -742,723.00 |
| Sep 30, 2021 | 818,489.00 |